The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inflammatory Bowel Disease Therapy Market Research Report 2025
Synopsis
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
The global Inflammatory Bowel Disease Therapy market was valued at US$ 17280 million in 2023 and is anticipated to reach US$ 22210 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
North American market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inflammatory Bowel Disease Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inflammatory Bowel Disease Therapy include Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease Therapy.
Report Scope
The Inflammatory Bowel Disease Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inflammatory Bowel Disease Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Segment by Type
Ulcerative Colitis
Crohns Disease
Others
Segment by Application
Hospital
Medical Research Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
The global Inflammatory Bowel Disease Therapy market was valued at US$ 17280 million in 2023 and is anticipated to reach US$ 22210 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
North American market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inflammatory Bowel Disease Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inflammatory Bowel Disease Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inflammatory Bowel Disease Therapy include Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease Therapy.
Report Scope
The Inflammatory Bowel Disease Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inflammatory Bowel Disease Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Segment by Type
Ulcerative Colitis
Crohns Disease
Others
Segment by Application
Hospital
Medical Research Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ulcerative Colitis
1.2.3 Crohns Disease
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Therapy Market Perspective (2019-2030)
2.2 Inflammatory Bowel Disease Therapy Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inflammatory Bowel Disease Therapy Historic Market Size by Region (2019-2024)
2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2025-2030)
2.3 Inflammatory Bowel Disease Therapy Market Dynamics
2.3.1 Inflammatory Bowel Disease Therapy Industry Trends
2.3.2 Inflammatory Bowel Disease Therapy Market Drivers
2.3.3 Inflammatory Bowel Disease Therapy Market Challenges
2.3.4 Inflammatory Bowel Disease Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2019-2024)
3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue
3.4 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2023
3.5 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapy Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2019-2024)
4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2025-2030)
5 Inflammatory Bowel Disease Therapy Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Application (2019-2024)
5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inflammatory Bowel Disease Therapy Market Size (2019-2030)
6.2 North America Inflammatory Bowel Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
6.4 North America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2019-2030)
7.2 Europe Inflammatory Bowel Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size (2019-2030)
8.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease Therapy Market Size (2019-2030)
9.2 Latin America Inflammatory Bowel Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
9.4 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size (2019-2030)
10.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction
11.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction
11.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.2.5 AbbVie Recent Development
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Company Detail
11.3.2 Takeda Pharmaceutical Company Business Overview
11.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction
11.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.3.5 Takeda Pharmaceutical Company Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction
11.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction
11.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.5.5 Celgene Corporation Recent Development
11.6 Innovate Biopharma
11.6.1 Innovate Biopharma Company Detail
11.6.2 Innovate Biopharma Business Overview
11.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction
11.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.6.5 Innovate Biopharma Recent Development
11.7 Cosmo Pharmaceuticals
11.7.1 Cosmo Pharmaceuticals Company Detail
11.7.2 Cosmo Pharmaceuticals Business Overview
11.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction
11.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.7.5 Cosmo Pharmaceuticals Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction
11.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.8.5 Gilead Sciences Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction
11.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2019-2024)
11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
